1. Home
  2. FCBM vs DTIL Comparison

FCBM vs DTIL Comparison

Compare FCBM & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Carolina Financial Services Inc.

FCBM

First Carolina Financial Services Inc.

N/A

Current Price

$13.06

Market Cap

404.8M

Sector

N/A

ML Signal

N/A

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

N/A

Current Price

$6.92

Market Cap

362.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FCBM
DTIL
Founded
2012
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
404.8M
362.6M
IPO Year
2026
2019

Fundamental Metrics

Financial Performance
Metric
FCBM
DTIL
Price
$13.06
$6.92
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$15.00
★ $29.40
AVG Volume (30 Days)
131.3K
★ 391.4K
Earning Date
10-27-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.71
N/A
Revenue
N/A
★ $1,070,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$22.18
$6.56
P/E Ratio
$18.54
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.17
$3.53
52 Week High
$14.00
$11.29

Technical Indicators

Market Signals
Indicator
FCBM
DTIL
Relative Strength Index (RSI) 46.90 43.14
Support Level $12.40 $6.12
Resistance Level $13.40 $7.80
Average True Range (ATR) 0.33 0.92
MACD -0.04 -0.24
Stochastic Oscillator 11.36 4.19

Price Performance

Historical Comparison
FCBM
DTIL

About FCBM First Carolina Financial Services Inc.

First Carolina Financial Services Inc is a bank holding company. The company's activities consist of managing and owning the Bank and its direct and indirect subsidiaries. The Bank provides commercial banking, payment, consumer banking, and wealth management services to small and medium-sized businesses, individuals, professionals, as well as institutions of higher education. It has four primary lines of business: Commercial Banking, Payments, Consumer Banking and Wealth Management. The reportable segments are Community Banking and BM Tech. The majority of revenue is derived from the Community Banking segment, which comprises activities of a traditional banking institution, gathering deposits and originating loans for portfolio in its respective primary market areas.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: